C2N Diagnostics Accelerates Global Expansion with Six New International Partnerships to Broaden Access to Alzheimer’s Blood Testing C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company committed to its mission of…
BioMendics Launches Landmark TAMES-02 Clinical Trial to Advance First-in-Class Therapy for Epidermolysis Bullosa Simplex BioMendics, a clinical-stage biopharmaceutical company specializing in the development of novel therapies for rare dermatologic conditions,…
CGT Global Strengthens Advisory Leadership with Appointment of Dr. Andrew Branagan, Enhancing Expertise in Hematologic Malignancies and Advanced Cell and Gene Therapy Development CGT Global, a biotechnology innovator dedicated to…
Melinta Therapeutics to Be Acquired by CorMedix in $300 Million Deal, Marking a Major Milestone in the Acute Care Pharmaceutical Sector Melinta Therapeutics, LLC (“Melinta”), a leading commercial-stage pharmaceutical company…
Precision BioSciences Reports Second Quarter 2025 Financial Results, Highlights Strong Clinical Progress in Gene Editing Programs, and Extends Cash Runway Into 2027 Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical-stage biotechnology…
Palleon Pharmaceuticals Initiates Phase 2 Clinical Trial of E-602 (HLX79) in Combination with HANLIKANG (Rituximab Biosimilar) for Patients with Active Glomerulonephritis Palleon Pharmaceuticals, a biotechnology company at the forefront of…
WuXi Biologics Earns Coveted Spot on CDP’s Supplier Engagement A List, Strengthening Its Position as a Global ESG Leader WuXi Biologics (2269.HK), a globally renowned Contract Research, Development, and Manufacturing…
BioHub Maryland and Bowie State University Join Forces to Empower the Next Generation of Life Sciences Talent In an ambitious initiative to cultivate a stronger, more diverse workforce in Maryland’s…
Bora Pharmaceuticals Unveils Multi-Year Expansion of Maple Grove Site as U.S. Growth Strategy Advances Post-Upsher-Smith Split Bora Pharmaceuticals Co., Ltd. (TWSE: 6472), a leading global contract development and manufacturing organization…
Promega and Aobious Reach Comprehensive Settlement in Patent Infringement Lawsuit Over Bioluminescent Technology Promega Corporation and Aobious Inc. have officially concluded a contentious legal battle over bioluminescent reagent patents, reaching…
U.S. Hospitals Achieve Significant Gains in Surgical Patient Outcomes Since 2019, AHA and Vizient Report Shows In a compelling new report released jointly by the American Hospital Association (AHA) and…
Kashiv BioSciences and MS Pharma Forge Strategic Alliance to Bring XOLAIR® Biosimilar ADL-018 to MENA Region Kashiv BioSciences, LLC, a U.S.-based biopharmaceutical company specializing in complex generics and biosimilars, and…